Miriam Kidron Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

Miriam Kidron is Chief Scientific Officer of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 1 Million shares of ORMP, which is worth approximately $2.25 Million. The most recent transaction as insider was on Jan 02, 2025, when has been sold 207,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1M

31.03% 3M change

31.03% 12M change

Total Value Held $2.25 Million

Miriam Kidron Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2025	BUY Grant, award, or other acquisition	-	207,000 Added 17.14%	1,000,666 Common Stock
Nov 07 2024	BUY Grant, award, or other acquisition	-	30,000 Added 3.64%	793,666 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	295,500 Added 27.9%	763,666 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	53,500 Added 10.26%	468,166 Common Stock
Apr 17 2023	BUY Grant, award, or other acquisition	-	213,000 Added 33.94%	414,666 Common Stock
Mar 14 2023	SELL Open market or private sale	$200,999 $2.01 p/Share	100,000 Reduced 33.15%	201,666 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	118,000 Added 28.12%	301,666 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	42,000 Added 18.61%	183,666 Common Stock
Aug 31 2021	BUY Grant, award, or other acquisition	-	66,666 Added 32.0%	141,666 Common Stock

Miriam Kidron

Chief Scientific Officer

Jerusalem, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Value

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

Operation

Value

Type

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Track Activities on ORMP

Account